DNA methylation analysis by MethyLight technology.

B N Trinh; T I Long; P W Laird

doi:10.1006/meth.2001.1268

Home/Archive/PubMed

PubMed · 11846615

DNA methylation analysis by MethyLight technology.

B N Trinh·T I Long·P W Laird

View original source ↗Export metadata ↓

Abstract

MethyLight is a sensitive, fluorescence-based real-time PCR technique that is capable of quantitating DNA methylation at a particular locus by using DNA oligonucleotides that anneal differentially to bisulfite-converted DNA according to the methylation status in the original genomic DNA. The use of three oligonucleotides (forward and reverse primers, and interpositioned probe) in MethyLight, any one or more of which can be used for methylation discrimination, allows for a high degree of specificity, sensitivity, and flexibility in methylation detection.

Explore related subjects

CpG Islands DNA Methylation DNA Primers Humans Models, Genetic Polymerase Chain Reaction Reverse Transcriptase Polymerase Chain Reaction Sensitivity and Specificity Sulfites Journal Article

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

B N Trinh, T I Long, P W Laird. 2001. DNA methylation analysis by MethyLight technology.. https://doi.org/10.1006/meth.2001.1268

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2006

Methylation in esophageal carcinogenesis.

Genetic abnormalities of proto-oncogenes and tumor suppressor genes have been demonstrated to be changes that are frequently involved in esophageal cancer pathogenesis. However, hypermethylation of CpG islands, an epigenetic event, is coming more and more into focus in carcinogenesis of the esophagus. Recent studies have proved that promoter hypermethylation of tumor suppressor genes is frequently observed in esophageal carcinomas and seems to play an important role in the pathogenesis of this tumor type. In this review, we will discuss current research on genes that are hypermethylated in human esophageal cancer and precancerous lesions of the esophagus. We will also discuss the potential use of hypermethylated genes as targets for detection, prognosis and treatment of esophageal cancer.

CpG Islands↗

PubMed2006

Molecular mechanisms in melanoma.

Explore the source record for details and available documents.

CpG Islands↗

PubMed2006

DNA hypomethylation and human diseases.

Changes in human DNA methylation patterns are an important feature of cancer development and progression and a potential role in other conditions such as atherosclerosis and autoimmune diseases (e.g., multiple sclerosis and lupus) is being recognised. The cancer genome is frequently characterised by hypermethylation of specific genes concurrently with an overall decrease in the level of 5 methyl cytosine. This hypomethylation of the genome largely affects the intergenic and intronic regions of the DNA, particularly repeat sequences and transposable elements, and is believed to result in chromosomal instability and increased mutation events. This review examines our understanding of the patterns of cancer-associated hypomethylation, and how recent advances in understanding of chromatin biology may help elucidate the mechanisms underlying repeat sequence demethylation. It also considers how global demethylation of repeat sequences including transposable elements and the site-specific hypomethylation of certain genes might contribute to the deleterious effects that ultimately result in the initiation and progression of cancer and other diseases. The use of hypomethylation of interspersed repeat sequences and genes as potential biomarkers in the early detection of tumors and their prognostic use in monitoring disease progression are also examined.

CpG Islands↗